Dr. Maria Zimina, Business Development Manager at SOM Biotech, attended “Hard Reg Café” of Regulatory Affairs meeting that took place on June 5 at the Barcelona Science Park (www.pcb.ub.edu). The event was organized by the CataloniaBio & HealthTech Regulatory Affairs Workgroup with the support of ACCIÓ (Government of Catalonia).
The main objective of the meeting was to share the key steps which biomedical companies and start-ups have to follow to gain Food and Drug Administration (FDA) approval for new drugs. During the meeting, specialists in Regulatory affairs from Reguliance (US) not only explained about particular requirements of FDA but also about specifics of Orphan Drug Designation (ODD), as well as covered the Comparison of Regulatory process in EU vs. the USA.
SOM Biotech is a European clinical-stage biopharmaceutical company with a strong pipeline of products focused on Orphan diseases at preclinical and clinical stages. One of the main assets of SOM Biotech – SOM3355 for treatment of the chorea movements associated with Huntington’s disease, is currently under Clinical Phase 2a. Additionally, one of the programs of SOM Biotech is almost ready to enter to Clinical Phase. Therefore, it is strategically important for SOM Biotech to have a deeper understanding of the FDA approval process so that it can open opportunities for development and approval of its products in the United States.
At SOM BIOTECH we use our own and third-party cookies to analyze the use made by users of the website to improve our services. For more information, please, check our cookies policy.
En SOM BIOTECH utilizamos cookies propias y de terceros para analizar el uso que hacen los usuarios del sitio web para mejorar nuestros servicios. Para más información, consulte nuestra política de cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.